Literature DB >> 9433462

Single-step purification of bispecific monoclonal antibodies for immunotherapeutic use by hydrophobic interaction chromatography.

O Manzke1, H Tesch, V Diehl, H Bohlen.   

Abstract

A method for large scale production and single-step purification of bispecific antibodies is described. Hybrid-hybridomas were grown in hollow-fibre bioreactors with an average yield of 8 to 12 g of immunoglobulin per month. Bispecific antibodies were purified from the bioreactor supernatant by hydrophobic interaction chromatography which resolves bispecific antibodies, monospecific immunoglobulins, and culture medium supplements in one single chromatographic step. Proteins were analyzed by ELISA, SDS-PAGE, isoelectric focussing, indirect fluorescence staining, CTL-stimulation and T-cell proliferation assays. Finally, antibody preparations were checked for the presence of endotoxin and mouse DNA. Our results suggest that functional bispecific antibodies for use in therapeutic applications can be batch purified from bioreactor harvest by hydrophobic interaction chromatography in a single step. Compared to other methods such as affinity chromatography (protein A/G), ion-exchange or hydroxyapatite chromatography, our protocol offers a substantial reduction in labor time, cost, protein loss, and risk of contamination.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9433462     DOI: 10.1016/s0022-1759(97)00129-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

Review 1.  Downstream processing in the biotechnology industry.

Authors:  Manohar Kalyanpur
Journal:  Mol Biotechnol       Date:  2002-09       Impact factor: 2.695

Review 2.  Recovery and purification process development for monoclonal antibody production.

Authors:  Hui F Liu; Junfen Ma; Charles Winter; Robert Bayer
Journal:  MAbs       Date:  2010-09-01       Impact factor: 5.857

Review 3.  Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: role as anticancer agents.

Authors:  S B Noonberg; C C Benz
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

4.  The bi-specific CD3 x NCAM antibody: a model to preactivate T cells prior to tumour cell lysis.

Authors:  M Jensen; K Ernestus; J Kemshead; M Klehr; M S Von Bergwelt-Baildon; T Schinköthe; J L Schultze; F Berthold
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

Review 5.  Current trends and challenges in the downstream purification of bispecific antibodies.

Authors:  Serene W Chen; Wei Zhang
Journal:  Antib Ther       Date:  2021-05-07

6.  An Integrated Approach to Aggregate Control for Therapeutic Bispecific Antibodies Using an Improved Three Column Mab Platform-Like Purification Process.

Authors:  Cassia Andrade; Lindsay Arnold; Dana Motabar; Matthew Aspelund; Alison Tang; Alan Hunter; Wai Keen Chung
Journal:  Biotechnol Prog       Date:  2018-10-17

7.  Conjugated detergent micelles as a platform for IgM purification.

Authors:  Gunasekaran Dhandapani; Ellen Wachtel; Ishita Das; Mordechai Sheves; Guy Patchornik
Journal:  Biotechnol Bioeng       Date:  2022-04-04       Impact factor: 4.395

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.